비장적출술로 호전된 불응성 혈전성 혈소판감소성 자반증 1예 = A Case of Splenectomy in a Patient with Refractory Thrombotic Thrombocytopenic Purpura

다국어 초록 (Multilingual Abstract)

The introduction of plasma exchange has significantly improved the outcome of thrombotic thrombocytopenic purpura (TTP) and the survival rate was increased from 10 to 80-90%. TTP refractory to plasma exchange therapy, however, is still a therapeutic challenge. We describe here a patient who partially responded to plasma exchange therapy, but remained dependent on plasma infusions. To discontinue plasma therapy, several attempts using agents such as rituximab, vincristine, and cyclosporine A had been tried, but all failed. After splenectomy, serum LDH and blood platelet count were normalized. Plasmapheresis were we able to discontinue after 2 weeks of splenectomy. Steroid and cyclosporine were tapered off after 3 months and 5 months after splenectomy respectively, and the patient has been staying in remission ever since. We suggest that splenectomy is a worthwhile treatment option in patients with refractory TTP.

참고문헌 (Reference)

1 이영진, "혈장교환술에 불응한 혈전성혈소판감소성자반증에서 비장절제술 1예" 대한진단검사의학회 26 (26): 119-122, 2006

2 Kim KH, "Von Willebrand Factor-Cleaving Protease Activity in Thrombotic Thrombocytopenic Purpura" 8 : 51-58, 2001

3 Moake JL, "Unusually large plasma factor VIII: von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura" 307 : 1432-1435, 1982

4 Kahwash E, "Twice daily plasma exchange in refractory thrombotic thrombocytopenic purpura" 8 : 254-257, 2004

5 Byrnes JJ, "Treatment of thrombotic thrombocytopenic purpura with plasma" 297 : 1386-1389, 1977

6 McCarthy LJ, "Thrombotic thrombocytopenic purpura: yesterday, today, tomorrow" 8 : 80-86, 2004

7 Cuttner J, "Thrombotic thrombocytopenic purpura: a ten-year experience" 56 : 302-306, 1980

8 Kremer Hovinga JA, "Splenectomy in relapsing and plasma-refractory acquired thrombotic thrombocytopenic purpura" 89 : 320-324, 2004

9 Kappers-Klunne MC, "Splenectomy for the treatment of thrombotic thrombocytopenic purpura" 130 : 768-776, 2005

10 Coppo P, "Réseau d'Etude des microangiopathies thrombotiques de l'Adulte : Prognostic value of inhibitory anti-ADAMTS13 antibodies in adult- acquired thrombotic thrombocytopenic purpura" 132 : 66-74, 2006

11 Aqui NA, "Role of splenectomy in patients with refractory or relapsed thrombotic thrombocytopenic purpura" 18 : 51-54, 2003

12 George JN, "Rituximab therapy for thrombotic thrombocytopenic purpura: a proposed study of the Transfusion Medicine/Hemostasis Clinical Trials Network with a systematic review of rituximab therapy for immune- mediated disorders" 21 : 49-56, 2006

13 Yomtovian R, "Rituximab for chronic recurring thrombotic thrombocytopenic purpura: a case report and review of the literature" 124 : 787-795, 2004

14 Furlan M, "Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis" 87 : 4223-4234, 1996

15 Allford SL, "Haemostasis and Thrombosis Task Force, British Committee for Standards in Haematology:Guidelines on the diagnosis and management of the thrombotic microangiopathic haemolytic anaemias" 120 : 556-573, 2003

16 Rock GA, "Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group" 325 : 393-397, 1991

17 Moschcowitz E, "An acute febrile pleiochromic anemia with hyaline thrombosis of the terminal arterioles and capillaries: an undescribed disease. 1925" 70 : 352-355, 2003

18 Furlan M, "Acquired deficiency of von Willebrand factor-cleaving protease in a patient with thrombotic thrombocytopenic purpura" 91 : 2839-2846, 1998

19 Yoon SY, "A Case of Splenectomy in a Patient with Chronic Relapsing Thrombotic Thrombocytopenic Purpura" 4 : 79-84, 1997